Search results
Results From The WOW.Com Content Network
Aerie Pharmaceuticals Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. Aerie's two lead product candidates are once-daily therapies for lowering intraocular pressure with mechanisms to treat patients ...
Shares of Aerie Pharmaceuticals surged 16.3% on Feb. 26 after the ophthalmic pharmaceutical company’s 4Q revenue topped the Street’s estimates. Revenue in the fourth quarter surged 23% ...
Aerie Pharmaceuticals (AERI) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.
Here is how AmerisourceBergen (ABC) and Aerie Pharmaceuticals (AERI) have performed compared to their sector so far this year.
For premium support please call: 800-290-4726 more ways to reach us
List of largest biomedical companies by revenue. The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange (as indicated) that have generated a revenue of at least US$ 10 billion, ranked by their revenue in the respective financial year. It does not include biotechnology companies that ...
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Donate
Aerie Pharmaceuticals is a spin-out from Duke research by co-founder Dr. David Epstein on retinal diseases, glaucoma and dry eye syndrome Durham pharma company acquired by international eye-care ...